Oppenheimer Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsOct 4 08:33 ET · Ratings

Laidlaw Initiates Aldeyra Therapeutics(ALDX.US) With Buy Rating, Announces Target Price $11

Moomoo NewsOct 3 18:32 ET · Ratings

Aldeyra Therapeutics Files Again for FDA OK of Dry-Eye Disease Treatment

WSJOct 3 08:27 ET

Express News | Aldeyra Therapeutics Inc - FDA Review of Nda Resubmission Expected Within 6 Months

ReutersOct 3 07:01 ET

Express News | Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

ReutersOct 3 07:00 ET

Express News | Aldeyra Therapeutics: Amendment Extends Expiration to April 1, 2026

ReutersOct 2 16:14 ET